Value of serum copeptin in the early diagnosis and short-term prognosis of acute myocardial infarction
-
摘要: 目的:探讨血清和肽素对急性心肌梗死(AMI)早期诊断及预后判断的价值。方法:选择因胸痛就诊且明确诊断为AMI的患者92例(AMI组),分别检测胸痛发作3h内及胸痛发作6、12和24h后血清和肽素、超敏肌钙蛋白T(hs-TnT)水平,并随访1年内主要心血管不良事件(MACE)的发生情况。另选择同期健康体检者60例作为对照组。结果:AMI组胸痛发作3h内血清和肽素水平较对照组明显升高[(1.00±0.45)ng/ml:(0.37±0.62)ng/ml,P<0.01],此时hs-TnT水平与对照组比较差异无统计学意义(P=0.553)。AMI组胸痛发作6、12h后血清和肽素水平较对照组明显升高[(0.64±0.39)ng/ml:(0.37±0.62)ng/ml、(0.89±0.45)ng/ml:(0.37±0.62)ng/ml,均P<0.01],此时hs-TnT水平亦较对照组明显升高[(0.81±1.07)ng/ml:0.014ng/ml、(0.74±0.82)ng/ml:0.014ng/ml,均P<0.01]。和肽素诊断AMI的ROC曲线下面积为0.900,优于hs-TnT的0.854(P<0.01)。随访12个月,AMI组8例发生MACE,且发生MACE者在胸痛发作24h后血清和肽素水平比未发生MACE者明显升高[(0.91±0.49)ng/ml:(0.39±0.13)ng/ml,P<0.01]。结论:血清和肽素水平对AMI的早期诊断(胸痛3h内)有较好的敏感性,胸痛发作24h后和肽素水平持续升高提示预后不佳。Abstract: Objective: To investigate the value of serum copeptin in the early diagnosis and short-term prognosis of acute myocardial infarction(AMI). Method: Ninety-two AMI patients with chest pain were recruited.The serum levels of copeptin and high sensitivity troponin T(hs-TnT) were detected in all patients within 3 h, 6 h, 12 h, and 24 h after onset of the chest pain.The major adverse cardiovascular events(MACE) were recorded during the follow-up of 12 months. Result: The copeptin level in AMI patients within 3 hours after the onset of pain was significantly higher than that in the normal control(P<0.01), but there was no significant difference in hs-TnT(P=0.553).The levels of serum copeptin and hs-TnT in AMI patients within 6 h or 12 h after the onset of pain were both higher than those in the normal control(P<0.01).The area under ROC curve of copeptin in diagnosis of AMI was better than hs-TnT(0.900 vs 0.854, P<0.01).During the follow-up of 12 months, 8 cases occurred MACE in AMI group, whose copeptin levels within 24 h after the onset of chest pain was significantly higher than those without MACE(P<0.01). Conclusion: Copeptin has a good sensitivity in the early diagnosis of AMI, and it can be used to assess the prognosis of AMI.Copeptin continuous rise indicates poor prognosis.
-
Key words:
- acute myocardial infarction /
- copeptin /
- early diagnosis /
- prognosis
-
-
[1] KELLER T, TZIKAS S, ZELLER T.et al.Copep-tin improves early diagnosis of acute myocardial in-farction[J].J Am Coll Cardiol, 2010, 55:2096-2106.
[2] MEUNE C, ZUILY S, WAHBI K.et al.Combina-tion of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment eleva-tion myocardial infarction:apilot study[J].Arch Cardiovasc Dis, 2011, 104:4-10.
[3] REICHLIN T, HOCHHOLZER W, STELZIG C, et al.Incremental value of copeptin for rapid rule out of acute myocardial infarction[J].J Am Coil Cardiol, 2009, 54:60-68.
[4] KHAN S Q, DHILLON Q S, O'BRIEN R J, et al.C-ter-minal provasopressin(copeptin)as a novel and prognostic marker in acute myocardial infarction:Leicester Acute My-ocardial Infarction Peptide(LAMP)study[J].Circulation, 2007, 115:2103-2110.
[5] VOORS A A, VON HAEHLING S, ANKER S D, et al.C-terminal provasopressin(copeptin)is a strong prognostic marker in patients with hear failure after an acute myocardial infarction:results from the OPTI-MAAL study[J].Eur Heart J, 2009, 30:1187-1194.
[6] 闫小菊, 刘松, 黄玉晓.血浆和肽素与急性心肌梗死患者近期预后的关系[J].临床心血管病杂志, 2011, 27(9):680-682.
-
计量
- 文章访问数: 207
- PDF下载数: 97
- 施引文献: 0